 |
 |
|
|
|
| |
|
| |
|
|
| |
Sadra Medical
Raises $9 Million In Series A Financing
Company seeks to transform heart valve therapy with innovative
technology
Sadra Medical, a privately-held, development stage Silicon Valley
firm dedicated to developing innovative new therapies for aortic
valve disease, has recently completed a $9M Series A round of
funding. Pequot Ventures co-led the financing, along with the
company’s original seed investors Onset Ventures and Schroder
Ventures.
"Our goal is to minimize the invasiveness of aortic valve
surgery, thereby improving patient care and making valve replacement
possible for patients who are too ill to undergo surgery,”
stated Amr Salahieh, President and CEO of Sadra Medical. “We’re
very motivated by the support of such a high caliber group of
investors."
Treatment of aortic valve disease remains a significant and
growing unmet clinical need. As many as 3 million people in
the U.S. have aortic stenosis; however, only a small percentage
of those are treated with the current standard of care, open-heart
surgery using cardiopulmonary bypass. By delivering a highly
effective aortic valve replacement that reduces the risks and
morbidity associated with surgery, Sadra Medical seeks to provide
a therapeutic option for patients who are not being treated
today.
Sadra Medical was founded in 2003 by Amr Salahieh and a couple
of leading-edge cardiovascular clinicians. Board members include
Salahieh, Leslie Bottorff of Onset Ventures, Juliet Bakker of
Pequot Ventures, Charles Warden representing Schroder Ventures,
and Fred Khosravi, CEO of AccessClosure.
About Pequot Ventures Pequot Ventures is the direct equity investment
arm of Pequot Capital Management, Inc., a leading asset management
firm with over $5.5 billion of capital under management. Pequot
Ventures was founded in 1996, has over $1.5 billion in capital
under management and has invested in over 150 companies in the
healthcare and technology sectors. The group has offices in
New York City, Menlo Park, Los Angeles, Wellesley, MA and Westport,
CT.
About Onset Ventures ONSET Ventures is a 20-year-old venture
capital firm specializing in early/seed stage information and
medical technology-based startups. Based in Menlo Park, CA,
ONSET has pioneered a shirt-sleeves style of active collaboration
with entrepreneurs to conceive and develop successful new businesses.
The firm has invested in over 100 companies, and has in excess
of $500 million under management.
About Schroder Ventures Schroder Ventures Life Sciences ('SVLS')
is a life sciences focused venture capital firm with funds totaling
$900M in capital. Schroder Ventures advised funds have invested
in the life sciences industry since the early 1980s and, to
date, have backed over 100 companies internationally. SVLS was
established in 1993 and currently has offices in London, Boston,
and San Francisco.
|
|
| |
|
|
|
|
|
|
|
|
